Gain-of-function c-kit mutations have been found to represent oncogenic driver events in the development of a wide variety of cancers/proliferative diseases, including GISTs [71,72], some subtypes of melanomas [73], mastocytosis [74], acute myeloid leukemia (AML) [75], and seminomas [76]. This evidence concerns the gene KIT and melanoma.